S Collins, I-Base: HIV and cancerUK-CAB April 2013 Introduction to HIV and cancer Simon Collins HIV i-Base.

Slides:

Advertisements

Similar presentations

Introduction to iVan Project. iVan = information van and is the Merseyside and Cheshire Cancer Networks Health Awareness, Information and Support Vehicle.

Advertisements

CHAIN Workshop, 14 March 2014 Simon Collins: Health service constraints on HIV care – the research agenda: a UK perspective CHAIN Workshop,

What we know about Health in BME Communities Dr. Sakthi Karunanithi Lancashire County Council.

Reducing Need and Demand for Health Care Gero 302 Jan 2011.

HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,

Chronic diseases in HIV Francois Venter Wits Reproductive Health & HIV Institute

Paula Kealey Senior Macmillan Development Manager 8 th May 2014 Partnership Working and Developments in Cancer Care.

April 6, o What is cancer? o Cancer statistics o Cancer prevention and early detection o Cancer disparities o Cancer survivorship o Cancer research.

Purposes and uses of cancer registration E.E.U. Akang Department of Pathology University College Hospital Ibadan, Nigeria.

Cancer Program Fewer Montanans experience late stage cancer. Fewer Montanans die of cancer. Metrics Biannual percent of Montanans who are up-to-date with.

Prostate Cancer Screening Assistant Professor Charles Chabert Men’s health Seminar Ballina April 2011 prostates.com.au.

HOW TO CONTROL CANCER Putting Science into Practice.

HSTAT1101: 27. oktober 2004 Odd Aalen

The “HELP” program Introducing case management approaches to HIV services in Lithuania Professor Malcolm Whitfield Sheffield Hallam University, UK.

Performance Monitoring : Thoughts, Lessons, and Other Practical Considerations.

Cervical Sample Taker Training 2015 THE NHS CERVICAL SCREENING PROGRAMME (NHSCSP)

START study: UK-CAB July2015 Community feedback: START study Simon Collins HIV i-Base

Clare Rogers Consultant Breast Surgeon Doncaster and Bassetlaw Hospitals.

HBV and HCV: America’s Hidden Epidemics Jeffrey Levi, PhD Trust for America’s Health October 14, 2010.

S Collins, HIV i-BaseUK CAB ACTIVIST TRAINING OCTOBER 2013 Science & research Simon Collins HIV i-Base i)why we need evidence and not just expert opinion.

Beyond Primary Treatment Professor Jane Maher Joint Chief Medical Officer Macmillan Cancer Support.

WLCCG Cancer QP Dr Pawan Randev WLCCG Cancer Lead GP 20 th June 2013.

Health Disparities Affecting Minorities African Americans.

Using HIV Surveillance to Achieve High Impact Prevention Irene Hall, PhD, FACE AIDS 2012 High-Impact Prevention: Reducing the HIV Epidemic in the United.

 Cancer is a group of more than 100 diseases that develop over time › Involve the uncontrolled division of the body’s cells  Cancer is the 2 nd leading.

Bloomsbury Clinic, May 2015 Simon Collins: Treatment update: generics Simon Collins i-Base.info.

“The African American Prostate Cancer Crisis in Numbers”

S Collins, HIV i-BaseUK CAB ACTIVIST TRAINING OCTOBER 2013 Tips for writing Simon Collins HIV i-Base.

HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.

HIV i-Base: SMART Study & CROI Feedback UK-CAB - Feb 2006 UK-CAB 24 February 2006 CROI Feedback: SMART Study Simon Collins.

Population Mortality and Morbidity in Ireland n April 2001.

National Perspective Cancer Early Detection & Prevention Performance Review Event October 2008 National Cancer Action Team Kathy Elliott National Lead.

HIV i-Base: Community outreach MRC April 2006 Community outreach in MRC national and international trials Simon Collins HIV i-Base, London UK-CAB and ECAB.

Module 3. Session Clinical Audit Prepared by J Moorman.

Martin Fisher Foundation: 14 September Remembering Martin Fisher Simon Collins, HIV i-Base Who should get tested? How and why should.

Rationalizing the New Healthcare Paradigm Scientific Agenda vs. Patient Imperatives Scientific Agenda vs. Patient Imperatives.

Introduction to Health Checks. Learning objectives Familiarisation with the Well Persons and Well Child Health Check tool Understand the relationship.

Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.

Performance assessment A performance assessment framework is a collation of statistics across a district or within a hospital and is far removed from.

Cancer Survivorship: Transforming how we deliver cancer care Catherine Neck Macmillan Cancer Rehabilitation/ Recovery Package Project Lead.

HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System Predictors for high viraemia among the treatment naïve population.

How clinicians use data to make an impact on clinical outcomes Andrew Brodbelt Consultant Neurosurgeon and Clinical Director of Neurosurgery, The Walton.

M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.

Ethnic Disparities of Oral Cancer Mortality Rates and Cost of Care in the Hispanic Population.

Adult Social Care and Health Select Committee Cancer in Nottingham Julie O’Boyle Specialty Registrar Public Health NHS Nottingham City Dr Chris Packham.

National Cancer Survivorship Initiative Central Hall, Westminster Monday 21 September 2009 Self Management.

Patterns of care and comparative effectiveness of endocrine therapy for premenopausal women with early breast cancer A multi-institution cohort study February.

2016 Implementing the Recovery Package. 1. Overview of Living with and Beyond Cancer 2.Promote wider understanding of Recovery Package 3.Explore stratification.

TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.

Non-communicable diseases (NCDs) include:

Benjamin Kearns, The University of Sheffield

Operational Plan 2017/18 and 2018/19

A Few Facts About Breast Cancer

Non-communicable diseases (NCDs) include:

Prevention and Early Diagnosis of Cancer Ongar Health Centre Patient Forum 7th March 2018 Sue White Cancer Research UK Facilitator.

BRIGHTLIGHT: from first glow to now – what, why and how

مقدمه في الرعايه الصحية HHSM301

Expanding the Universe of Viral Hepatitis Treaters

Cancer Research Early Diagnosis Research Conference: ECR Pechakucha presentation: Feb 2017 Exploring patient and practitioner perspectives of QCancer.

Local networking sessions

Tit Albreht | Brussels | 7 November 2017

NHS Breast Screening Programme

VACS Risk Index Refinement and further validation

The Rising Crisis of Prediabetes Diagnosis and Management of the Patient With Prediabetes.

Operational Plan 2017/18 and 2018/19

monitoring & evaluation THD Unit, Stop TB department WHO Geneva

Cancer Survivorship: Transforming how we deliver cancer care

Surveillance, Monitoring and Evaluation Working Group

Greater Manchester Cancer

Presentation transcript:

S Collins, I-Base: HIV and cancerUK-CAB April 2013 Introduction to HIV and cancer Simon Collins HIV i-Base

S Collins, I-Base: HIV and cancerUK-CAB April 2013 Introduction Area of expert care – referrals and networks BHIVA guidelines Personal aims for the day? HIV and cancer – general points HIV and cancer – scientific concepts Activist agenda? Personal comments

S Collins, I-Base: HIV and cancerUK-CAB April 2013 HIV and cancer We are lucky to be ageing… But cancer is often an age-related disease - highest risk comes with age >75% of people have a lifetime cancer risk - is this a natural ageing process? Over 200 cancers – each very specific Many are treatable, with high (>90%) remission rates if detected early (screening / surveillance / self monitoring etc) Some are not - make the most of life.

S Collins, I-Base: HIV and cancerUK-CAB April 2013 HIV and cancer Expert care essential Cancer treatment is very different to ART - less data for modified combinations, best guess approach. Extended timelines forprogression, treatment and treatment outcomes. Risks are multi-factorial and often related to modifiable lifestyle factors. Personal perspective - prioritise your health.

S Collins, I-Base: HIV and cancerUK-CAB April 2013 HIV and cancer: scientific issues Difficulty of knowing any independent risk from HIV – impact of ART/non- ART and viral suppression. Difficultly of not having an appropriate matched control group. Higher rates reported for some and at earlier age – but adjusting for cohort ages of reduced the differences in both incidence and age at diagnosis.

S Collins, I-Base: HIV and cancerUK-CAB April 2013 HIV and cancer: scientific issues Relative vs absolute risks Issues of screen and risk/benefit balance with screening. Common sense approach for broad screening programmes is not always supported by evidence. Difficulty of separating earlier diagnosis and mortality. Activist role/agenda

S Collins, I-Base: HIV and cancerUK-CAB April 2013 Thanks Further info Macmillan BHIVA malignancy guidelines UK-CAB reading for April 2013 meeting, including: Do cancer patients with HIV die sooner? – Mark Bower. x